These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


516 related items for PubMed ID: 11325394

  • 21. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
    Rogóz Z, Dziedzicka-Wasylewska M.
    Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
    [Abstract] [Full Text] [Related]

  • 22. Differential effects of 7-OH-DPAT on amphetamine-induced stereotypy and conditioned place preference.
    Khroyan TV, Baker DA, Fuchs RA, Manders N, Neisewander JL.
    Psychopharmacology (Berl); 1998 Oct; 139(4):332-41. PubMed ID: 9809854
    [Abstract] [Full Text] [Related]

  • 23. Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys.
    Sinnott RS, Mach RH, Nader MA.
    Drug Alcohol Depend; 1999 Apr 01; 54(2):97-110. PubMed ID: 10217549
    [Abstract] [Full Text] [Related]

  • 24. Apomorphine and 7-OH DPAT reduce ethanol intake of P and HAD rats.
    Russell RN, McBride WJ, Lumeng L, Li TK, Murphy JM.
    Alcohol; 1996 Apr 01; 13(5):515-9. PubMed ID: 8888949
    [Abstract] [Full Text] [Related]

  • 25. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
    Richtand NM, Welge JA, Levant B, Logue AD, Hayes S, Pritchard LM, Geracioti TD, Coolen LM, Berger SP.
    Neuropsychopharmacology; 2003 Aug 01; 28(8):1422-32. PubMed ID: 12700693
    [Abstract] [Full Text] [Related]

  • 26. Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine.
    Mattingly BA, Rowlett JK, Graff JT, Hatton BJ.
    Psychopharmacology (Berl); 1991 Aug 01; 105(4):501-7. PubMed ID: 1837610
    [Abstract] [Full Text] [Related]

  • 27. Stimulus and response factors affecting the development of behavioral sensitization to apomorphine.
    Mattingly BA, Koch C, Osborne FH, Gotsick JE.
    Psychopharmacology (Berl); 1997 Mar 01; 130(2):109-16. PubMed ID: 9106907
    [Abstract] [Full Text] [Related]

  • 28. Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine.
    Mattingly BA, Hart TC, Lim K, Perkins C.
    Psychopharmacology (Berl); 1994 Mar 01; 114(2):239-42. PubMed ID: 7838914
    [Abstract] [Full Text] [Related]

  • 29. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments.
    Mattingly BA, Rowlett JK, Ellison T, Rase K.
    Pharmacol Biochem Behav; 1996 Mar 01; 53(3):481-6. PubMed ID: 8866944
    [Abstract] [Full Text] [Related]

  • 30. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
    Chagas-Martinich L, Carey RJ, Carrera MP.
    Pharmacol Biochem Behav; 2007 Mar 01; 86(3):441-8. PubMed ID: 17291574
    [Abstract] [Full Text] [Related]

  • 31. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun 01; 15(3):247-52. PubMed ID: 7584718
    [Abstract] [Full Text] [Related]

  • 32. 7-OH-DPAT injected into the accumbens reduces locomotion and sucrose ingestion: D3 autoreceptor-mediated effects?
    Gilbert DB, Cooper SJ.
    Pharmacol Biochem Behav; 1995 Oct 01; 52(2):275-80. PubMed ID: 8577791
    [Abstract] [Full Text] [Related]

  • 33. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.
    Rodríguez De Fonseca F, Rubio P, Martín-Calderón JL, Caine SB, Koob GF, Navarro M.
    Eur J Pharmacol; 1995 Feb 14; 274(1-3):47-55. PubMed ID: 7768280
    [Abstract] [Full Text] [Related]

  • 34. Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice.
    Yarkov AV, Hanger D, Reploge M, Joyce JN.
    Pharmacol Biochem Behav; 2003 Dec 14; 76(3-4):551-62. PubMed ID: 14643855
    [Abstract] [Full Text] [Related]

  • 35. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning.
    Khroyan TV, Baker DA, Neisewander JL.
    Psychopharmacology (Berl); 1995 Dec 14; 122(4):351-7. PubMed ID: 8657832
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The locomotor effects of a putative dopamine D3 receptor agonist in developing rats.
    Frantz K, Babcock D, Van Hartesveldt C.
    Eur J Pharmacol; 1996 Apr 29; 302(1-3):1-6. PubMed ID: 8790984
    [Abstract] [Full Text] [Related]

  • 38. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats.
    Van den Buuse M.
    Eur J Pharmacol; 1993 Oct 19; 243(2):169-77. PubMed ID: 8276066
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats.
    Rogóz Z, Skuza G, Kłlodzińska A.
    Pol J Pharmacol; 2004 Oct 19; 56(5):519-26. PubMed ID: 15591639
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.